Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis

INTRODUCTION: High body mass index (BMI) is associated with risk of diabetes. Lorcaserin is a selective 5-hydroxytryptamine 2C agonist which exerts robust benefits on long-term weight loss by suppressing appetite among adults with overweight or obesity. The magnitude of efficacy of lorcaserin for pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Hai, Luo, Meng, Li, Zunjiang, Wen, Junru, He, Guoxin, Jin, Yuelin, Fu, Wenbin, Zhou, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661621/
https://www.ncbi.nlm.nih.gov/pubmed/31352420
http://dx.doi.org/10.1136/bmjopen-2019-029426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661621/
https://www.ncbi.nlm.nih.gov/pubmed/31352420
http://dx.doi.org/10.1136/bmjopen-2019-029426

Ejemplares similares